EventsThe Eighteenth International Conference of Experimental Mechanics
Published
This submission belongs to the session ICEM. ICEM 2018 of the event The Eighteenth International Conference of Experimental Mechanics
Published date
09 May, 2018
Citation
Igor Saveljic, Dalibor Nikolic, Zarko Milosevic, Velibor Isailovic, Milica Nikolic, Parodi Oberdan, Nenad Filipovic, 446 3D modeling of plaque progression in the human coronary artery, in Proceedings of The Eighteenth International Conference of Experimental Mechanics, Brussels, 1 July–5 July 2018, MDPI: Basel, Switzerland, doi: 10.3390/ICEM18-05213
Share
Email
Facebook
Twitter
LinkedIn

446 3D modeling of plaque progression in the human coronary artery

image
Zarko Milosevic 2
Velibor Isailovic 1
Milica Nikolic 1
image
1. Faculty of Engineering, University of Kragujevac, 34000 Kragujevac, Serbia
2. Bioengineering Research and Development Center, 34000 Kragujevac, Serbia
3. National Research Council Pisa, Italy
Abstract

The inflammation and lipid accumulation in the arterial wall represents a progressive disease known as atherosclerosis. In this study, a numerical model of atherosclerosis progression was developed. The wall shear stress (WSS) and blood analysis data have a big influence on the development of this disease. The real geometry of patients, and the blood analysis data (cholesterol, HDL, LDL, and triglycerides), used in this paper, was obtained within the H2020 SMARTool project. Fluid domain (blood) was modeled using Navier-Stokes equations in conjunction with continuity equation, while the solid domain (arterial wall) was modeled using Darcy’s law. For the purpose of modeling low-density lipoprotein (LDL) and oxygen transport, convection-diffusion equations were used. Kedem-Katchalsky equations were used for coupling fluid and solid dynamics.

Keywords
low-density lipoprotein
coronary artery
plaque concentration
wall shear stress
148 Experimental and numerical investigation on the impact response of elastomer-coated concrete
463/ LAB-ON-CHIP PROTOTYPE FOR THE DETECTION OF CORONARY ARTERY DISEASE BIOMARKERS